Certificate of Analysis
Tirzepatide (60mg) · Batch NPT-2026-0009
NOVATIDE
Peptide Research Laboratories
Certificate of Analysis
NPT-2026-0009
Product Name
Tirzepatide (60mg)
Batch Details
Analytical Results
| Test | Method | Specification | Result | Status |
|---|---|---|---|---|
| Purity | HPLC (C-18, 220 nm) | ≥ 98.0% | 99.1% | ✓ Pass |
| Identity | ESI-MS | Match to reference | Confirmed | ✓ Pass |
| Appearance | Visual | White lyophilized powder | Conforms | ✓ Pass |
| Solubility | Bacteriostatic Water | Soluble | Soluble | ✓ Pass |
| Sterility | USP <71> | Sterile | Pass | ✓ Pass |
| Endotoxin | LAL | < 0.5 EU/mg | < 0.1 EU/mg | ✓ Pass |
HPLC Chromatogram
Representative chromatogram. Main peak area: 99.1%. Total impurity area: 0.9%.
Released for Research Use
This batch meets all release specifications for research-grade peptide supply. Analyzed by third-party accredited laboratory. Signed and archived per internal QC protocol.
For Research Use Only. This product is supplied strictly as a research chemical. It is not a drug, food, cosmetic, dietary supplement, or medical product. Not intended for human or animal consumption, administration, diagnostic use, therapeutic use, or clinical use.
Novatide Peptides · novatidepeptide.com · support@novatidepeptide.com
Document ID: CoA-NPT-2026-0009 · Generated April 6, 2026